The GV-backed stem cell drug developer has set terms for an initial public offering that would raise between $300m and $345m.

The Tencent and WMG-backed game development platform operator, valued at $29.5bn as of last month. is pausing its direct listing plans due to regulatory scrutiny.

The New York Stock Exchange, BBVA, Docomo Capital and USAA-backed crypto trading platform operator is changing tack from an IPO to a direct listing.

Harvard-linked Sana Biotechnology will raise as much as $397m if it floats at the upper end and underwriters take up the greenshoe option.

The Tencent and Baidu-backed short-form video platform developer priced an offering valuing it at about $61bn at the top of its range.

The China Evergrande-backed mobility technology producer is joining forces with special purpose acquisition company Property Solutions Acquisition Corp.

DMGT, Baidu, Advance Publications, Yahoo Japan and Comcast-backed content recommendation software provider Taboola will get an NYSE listing through the deal.

The smart lock provider is merging with a SPAC set up by real estate manager Tishman Speyer, an existing investor, at a $1.56bn post-money valuation.

The Regeneron, Alphabet and GlaxoSmithKline-backed hearing loss therapy developer has filed to raise up to $75m in its initial public offering.

Landos has filed to go public after a phase 2 trial of its Virginia Tech-invented IBD treatment produced favourable results this month.